Copley Scientific has launched new technologies to help developers of generic inhalable drugs stick to specific testing guidelines issued by the US FDA and USP.
Pharmacopoeial standards authorities must cooperate to develop rigorous quality standards for drugs in an increasingly globalised market, according to the SFDA.
Melbourn Scientific has invested in a light obscuration particle
counter to size and count particles in liquid samples using light
microscopy, to expand the company's capacity in stability testing
and to increase throughput and...